Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kenneth R. Hallows, Viswanathan Raghuram, Bruce E. Kemp, Lee A. Witters, J. Kevin Foskett
Published in Volume 105, Issue 12
J Clin Invest. 2000; 105(12):1711–1721 doi:10.1172/JCI9622
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

In vitro phosphorylation of CFTR by AMPK. CFTR was immunoprecipitated from CHO-BQ2 cell lysates (lanes 2–5) before phosphorylation, SDS-PAGE, and autoradiography. In lane 2, no exogenous kinase was added to the phosphorylation buffer. In lanes 3 and 4, affinity-purified AMPK holoenzyme was added to immunoprecipitated CFTR in the absence or presence of 0.2 mM AMP, respectively. Affinity-purified α1-1-312 was added to immunoprecipitate in lane 5. As a negative control, AMPK holoenzyme was added to an immunoprecipitate from CHO cells that do not express CFTR (lane 1). Results shown are representative of three replicate experiments.